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Purpose or Objective: The emergence of MRI-guided 
radiotherapy has led to the development of new radiotherapy 
treatment machines with integrated MR-imaging systems. 
Several designs have emerged such as the 60Co ViewRay 
system and the different MRI-linac systems developed 
independently by Utrecht/Elekta, the Cross Cancer Institute 
in Canada and the Ingham Research Institute in Australia. 
Magnetic (B-)fields do not alter the photon energy fluence of 
the beam but they do change the dose distribution in water. 
Therefore the quantity that is used to specify the beam 
quality of an MRI-RT device must ideally be insensitive to 
these changes. The purpose of this study was to investigate 
the sensitivity of the two most standard beam quality 
specifiers (%dd(10)x and TPR20,10) to the presence of the B-
field. 
 
Material and Methods: Depth dose curves and tissue phantom 
ratio at depths of 20 and 10 cm (TPR20,10) values with and 
without a 1.5 T B-field were calculated using the Geant4 
Monte Carlo toolkit with the energy spectrum from an Elekta 
MRI-linac used as a source. For comparison, TPR20,10 values 
were also measured with a NE2571 Farmer chamber in a 
water-equivalent plastic phantom on an Elekta MRI-linac with 
and without the 1.5 T B-field. 
 
Results: The measured and calculated TPR20,10 values 
agreed within 0.3%. The Lorentz force acts perpendicularly to 
the direction of motion of the secondary electrons causing 
them to move in spirals which shortens their range. This 
reduces the depth of the build-up region and enhances the 
dose per primary photon at the depth of maximum dose 
(dmax). On the other hand, the dose at depths where 
transient charged particle equilibrium (CPE) exist are 
relatively unaffected by the B-field. Consequently, the 
photon component of the percentage depth dose at 10 cm 
depth, %dd(10)x, changes by 2.4% when the B-field is applied 
because this value is normalized to dmax. However, the 
calculated and measured values of the TPR20,10 changed by 
only 0.1% and 0.3% respectively due to the fact that both 
depths (10 and 20 cm) are in regions of transient CPE. 
 
 
 
Figure 1: Depth dose curves per primary photon with and 
without a 1.5 T magnetic field. 
 
 
 
Table 1: Measured and calculated TPR20,10 values as well as 
calculated percentage depth dose data with and without a 
1.5 T magnetic field. %dd(10)x is the photon component of 
the percentage depth dose at 10 cm water depth. %dd(10) 
contains electron contamination. 
 
Conclusion: The TPR20,10 beam quality specifier is more 
consistent in the presence of B-fields than the %dd(10)x 
specifier. 
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Purpose or Objective: To investigate the feasibility of using 
3D Fricke-type gel dosimeters for “real-time” dose 
observations using the combined 1.5 T MRI – 6 MV linear 
accelerator system (MRL). 
 
Material and Methods: Fricke-type dosimeters were prepared 
in 97% w/w Milli-Q water with 3% w/w gelatin (300 Bloom), 1 
mM ferrous ion, 0.05 mM xylenol orange, 50 mM sulfuric acid, 
and 1 mM sodium chloride. The dosimeters were stored at 4 
°C prior to irradiation and imaging. For this preliminary 
study, the dosimeters were irradiated in air, with a part of 
each dosimeter outside the treatment field to act as a 
reference. MR imaging was performed with the MRL to 
observe the change in paramagnetic properties pre and post 
irradiation using a T1-weighted sequence of TR = 500 ms and 
TE = 20 ms. MRI during irradiation was done in the MRL using 
a fast sequence of TR = 5 ms and TE = 1.7 ms. 
 
Results: When exposed to ionizing radiation, ferrous ions are 
oxidized to ferric ions forming a 1:1 xylenol orange – ferric 
complex in radiochromic Fricke dosimeters. The 
corresponding changes in paramagnetic properties can be 
measured using an MRI. The paramagnetic spin changes, 
which are dependent on the concentrations of ferrous and 
ferric ion species, were observable on T1-weighted images 
due to changes in the spin-lattice relaxation rate (R1 = 1/T1). 
We observed a mean increase in pixel value of 53% from un-
irradiated to irradiated regions of about 20 Gy. The increase 
in pixel value and corresponding dose was also visible during 
irradiation using a fast MR sequence with four snapshots 
included in the figure (in RGB color scale to emphasize the 
irradiated region). Visibly, the dosimeter underwent a color 
change from yellow to purple with the formation of the 
xylenol orange – ferric complex. 
 
 
 
Conclusion: Our Fricke-type dosimeters displayed visible 
ferric complex formation with xylenol orange after 
irradiation using the 6 MV linear accelerator component of 
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the MRL, as well as measurable paramagnetic changes 
observed using the 1.5 T MRI component of the MRL during 
and after irradiation. To our knowledge, this is the first time 
the dose accumulation inside a 3D dosimeter has been 
visualized in real-time during irradiation using the MRL. The 
results of this study warrant further investigations into the 
use of 3D dosimeters for the verification of patient specific 
radiation therapy treatment plans for the MRL. 
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Purpose or Objective: In radiotherapy, the development of 
bidimensional detectors with the suitable dosimetric features 
for pretreatment quality assurance of the new advanced 
treatment techniques is of interest. Diamond is a valid 
candidate as real-time dosimeter since, contrary to silicon, it 
is an almost tissue equivalent material showing in principle 
no energy dependence. Furthermore, it is possible to product 
large-area polycrystalline diamond wafers with suitable 
electronic properties. In this study we describe the 
performance of DIAPIX, a large area dosimeter used for 
pretreatment verification of intensity modulated treatment 
plans. 
 
Material and Methods: The dosimeter is made of two 
detector-grade adjacent 2.5x2.5cm2 polycrystalline Chemical 
Vapour Deposited (pCVD) diamond samples, each equipped 
with a 12x12 matrix of 144 contacts with a pitch of 2mm, 
connected to a custom-made electronic read-out system. 
Tests of the pCVD diamond dosimeter have been performed 
by means of an Elekta Synergy LINAC, with conventional 
photon beams, with clinical IMRT fields, from prostate and 
breast cancer, and with a VMAT lung treatments. The 
dosimeter was placed at the isocenter and sandwiched inside 
a phantom of water equivalent material. First set of 
measurements under a conventional radiotherapy beam 
aimed to verify the correct behavior of the whole matrix 
under a flat field and to obtain a flatness correction factor 
for each pixel were performed. Afterwards dosimetric maps 
were acquired. Since the area of the prototype under study is 
smaller respect to a typical IMRT field, the dosimeter was 
firstly positioned at the isocenter and then shifted in the 
Latero-Lateral direction. QA plans were computed on the 
phantom using the Treatment Planning System (TPS) Monaco 
v3.2., which uses a MonteCarlo algorithm to compute the 
dose distribution, with a dose grid of 2 mm, and Pinnacle 
v9.2 which uses a collapsed cone convolution respectively for 
the VMAT and IMRT plan. 
 
Results: A comparison between the measured maps and the 
ones predicted by the TPS was performed. As an example, in 
fig 1 is reported the map collected of lung VMAT plan and the 
comparison between the measured profiles of some pixels 
and the ones calculated by Monaco TPS. Dose differences 
with TPS are in general within 5%, apart in the penumbra 
region where the dose gradient is high and where the 
distance-to-agreement is within 3mm. 
 
 
Conclusion: Dose profiles compare favorably with TPS both 
for IMRT and VMAT. These results demonstrate that the pCVD 
diamond device is a suitable detector for dosimetric pre-
treatment verification analysis in modulated radiation 
therapy and for conformal beams. This allows for the 
development of a large area monolithic device with high 
spatial resolution. In a next future, three samples will be put 
together in order to realize a matrix with 432 pixels with a 
total area of 7.5x2.5 cm2.  
This work has been supported by the experiments INFN CSN5 
DIAPIX and IRPT/MIUR. 
 
Poster: Physics track: Dose measurement and dose 
calculation  
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Purpose or Objective: The quality of beam base data (BBD) 
is crucial for the accuracy of dose computation, because 
every measurement error translates into a systematic dose 
computation error. Despite elaborate guidelines and 
recommendations, the quality of BBD measurements cannot 
be verified directly. This constitutes a gap in the clinical QA 
chain. We present a Monte-Carlo (MC) based method to 
validate the self-consistency and overall quality of typical 
BBD measurements. 
 
Material and Methods: BBD are naturally not independent; 
therefore, self-consistency is a sensitive indicator. Ideally, a 
full MC simulation, starting with the primary electron beam, 
would allow benchmarking of individual measurements. This 
requires that the electron beam properties are known, which 
can in turn only be determined indirectly from measurements 
of the photon fields, resulting in a circular problem; not to 
mention that full linac simulations with a final uncertainty fit 
for this purpose still require a long time. Thus, we propose: 
for each accelerator type, a number of electron beam tunes 
are simulated with BEAMnrc and the phase spaces recorded. 
The phase spaces are then decomposed into 5 sources and 
each source is described by a parametric model. The model 
parameters are naturally highly correlated and yield a unique 
parameter fingerprint of the beam tune. Given that the 
photon dose distribution of each source is known, the model 
parameters of a BBD set can be derived by a fitting process. 
If a parameter fingerprint of a measurement does not follow 
